Breaking News
Investing Pro 0
Final hours: unlock premium data with Claim 60% OFF

Glenmark Pharma shares drop following major divestment of subsidiary

Published Sep 22, 2023 02:38AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
GLEN
-3.02%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GLEM
+0.01%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Shares of Mumbai-based Glenmark Pharmaceuticals fell 4.5% to Rs 790.25 on the National Stock Exchange (NSE) in early trade on Friday, following the company's announcement of a significant divestment in its subsidiary, Glenmark Life Sciences. The decline came after the stock reached a 52-week high of Rs 880 on Thursday.

The pharmaceutical giant has entered into an agreement with Nirma Limited to sell a substantial 75% stake in Glenmark Life Sciences, which totals 91.89 crore shares priced at Rs 615 per share. The decision to sell this stake, equivalent to 91,895,379 shares and valued at Rs 5,651.5 crore, was approved during a board meeting held on Thursday, September 21, 2023.

As part of the sale agreement, both Glenmark Life Sciences and Nirma have agreed to certain non-compete and non-solicit arrangements for a predetermined period. Despite this significant divestment, Glenmark Pharma will retain a minor stake of 7.84% in Glenmark Life Sciences.

Glenn Saldanha, Chairman and Managing Director of the company, views the transaction with Nirma as a strategic move that aligns with Glenmark's intent to ascend up the value chain. This deal is perceived as a step towards transforming Glenmark into an innovative and brand-led organization focusing on core therapeutic areas such as dermatology, respiratory, and oncology.

The divestment also provides an opportunity for the company to enhance shareholder value by reducing debt and improving its overall return profile. Further updates on this story will be provided as they become available.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Glenmark Pharma shares drop following major divestment of subsidiary
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email